Biomica’s Investor Meeting & Workshop 2024 Hong Kong

Biomica and Shanghai Healthcare Capital (SHC) were delighted to host an inspiring investor meeting and workshop in Hong Kong, in December 2024, bringing together leading academics, local investors, researchers, and partners.

Dr. Elran Haber, Biomica’s CEO, presented the company’s cutting-edge advancements in microbiome-based therapeutics, while Prof. Gal Markel shared his insights into the transformative potential of these therapies in oncology.

Dr. Jing Bao, Partner at SHC and Biomica Board Member, along with Mr. Ofer Haviv, CEO of Evogene and Chairman of Biomica, also attended the event, expressing their confidence in Biomica’s promising initiatives.

We trust the discussions provided valuable insights into the opportunities within this rapidly evolving field and look forward to cultivating future collaborations.